Bedford, MA, United States of America

Ganesh Kaundinya

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Bedford, MA (US) (2014 - 2019)
  • Cambridge, MA (US) (2019 - 2022)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Ganesh Kaundinya: Innovator in Neurodegeneration Treatment

Introduction

Ganesh Kaundinya is a prominent inventor based in Bedford, MA (US). He has made significant contributions to the field of neurodegeneration treatment, holding a total of 9 patents. His work focuses on innovative methods that aim to address neurodegenerative diseases, including Alzheimer's Disease.

Latest Patents

Kaundinya's latest patents revolve around the discovery of Fc-containing polypeptides that include branched glycans. These polypeptides are sialylated on the branched glycan, specifically on an α 1,3 and/or α 1,6 arm in the Fc region's N-linked glycosylation site. The invention highlights the utility of these polypeptides in treating neurodegeneration. The methods disclosed involve administering compositions containing these Fc-containing polypeptides, as well as techniques for evaluating, identifying, and producing them for therapeutic purposes.

Career Highlights

Ganesh Kaundinya is currently associated with Momenta Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating debilitating neurodegenerative conditions.

Collaborations

Kaundinya collaborates with notable colleagues, including Carlos J Bosques and Thomas E Prod'Homme. Their combined expertise contributes to the development of groundbreaking treatments in the field of neurodegeneration.

Conclusion

Ganesh Kaundinya's innovative work in neurodegeneration treatment exemplifies the importance of research and development in addressing complex medical challenges. His contributions are paving the way for new therapeutic approaches that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…